| P50 | author | Andrew Shelling | Q47546535 |
| P2093 | author name string | Annette Lasham | |
| | Asad Ullah Madani | |
| | Priyanka Tharkar | |
| | Raida Al-Kassas | |
| P2860 | cites work | Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. | Q51323099 |
| | FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. | Q51627790 |
| | Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications | Q57183208 |
| | Multifunctional core–shell nanoparticles: superparamagnetic, mesoporous, and thermosensitive | Q57347977 |
| | Fabrication of functional block copolymer grafted superparamagnetic nanoparticles for targeted and controlled drug delivery | Q57351482 |
| | Antibody-Conjugated Nanoparticles for Biomedical Applications | Q58648259 |
| | Nanotechnology-mediated targeting of tumor angiogenesis | Q21195857 |
| | Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? | Q24599399 |
| | Drug delivery and nanoparticles:applications and hazards | Q24655744 |
| | A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors | Q25257257 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | The origin of pegnology | Q28203078 |
| | Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Q29614969 |
| | Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications | Q29615464 |
| | Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 |
| | In vivo cancer targeting and imaging with semiconductor quantum dots | Q29617278 |
| | Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention | Q30858524 |
| | Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma | Q30890447 |
| | Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system | Q33297462 |
| | Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells | Q33539248 |
| | Effect of Fe(3)O(4)-magnetic nanoparticles on acute exercise enhanced KCNQ(1) expression in mouse cardiac muscle | Q33738469 |
| | Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy | Q33774864 |
| | Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles | Q33860710 |
| | Resistance mechanisms associated with altered intracellular distribution of anticancer agents. | Q33876883 |
| | Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy | Q33933206 |
| | Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study | Q33958866 |
| | Magnetic nanoparticles: synthesis, protection, functionalization, and application | Q34002262 |
| | Dendrimers and supramolecular chemistry | Q34022064 |
| | Luminescent quantum dots for multiplexed biological detection and imaging | Q34114579 |
| | Ligand-targeted therapeutics in anticancer therapy | Q34152775 |
| | Theranostic nanoshells: from probe design to imaging and treatment of cancer | Q34187209 |
| | The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting | Q34268743 |
| | Nanoshell-enabled photonics-based imaging and therapy of cancer | Q34293561 |
| | Quantum dot bioconjugates for imaging, labelling and sensing | Q34422922 |
| | Estimating the world cancer burden: Globocan 2000. | Q34518922 |
| | Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity | Q34595551 |
| | Core/Shell semiconductor nanocrystals | Q34925225 |
| | In vivo quantum-dot toxicity assessment | Q35002034 |
| | Breast cancer revisited using DNA array-based gene expression profiling | Q35031407 |
| | EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance | Q39783093 |
| | Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome | Q40116440 |
| | Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. | Q40377022 |
| | Gold nanoshell bioconjugates for molecular imaging in living cells | Q40419530 |
| | A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate. | Q40643488 |
| | Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a "smart" drug delivery system to breast cancer cell therapy | Q42240498 |
| | Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots | Q42807706 |
| | Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles | Q42813357 |
| | Application of nanotechnology in cancer research: review of progress in the National Cancer Institute's Alliance for Nanotechnology | Q42957834 |
| | A novel carboxymethyl chitosan-quantum dot-based intracellular probe for Zn2+ ion sensing in prostate cancer cells | Q44216907 |
| | Quantum dot applications to neuroscience: new tools for probing neurons and glia. | Q45996007 |
| | Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications | Q35086100 |
| | Targeted therapies for breast cancer | Q35372584 |
| | Solid lipid nanoparticles for parenteral drug delivery. | Q35756600 |
| | Breast cancer classification and prognosis based on gene expression profiles from a population-based study | Q35918291 |
| | Nanotechnology for cancer diagnostics: promises and challenges | Q36481101 |
| | Reasons for breast cancer heterogeneity | Q36489452 |
| | Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery | Q36575155 |
| | Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology | Q36615101 |
| | Nanotechnology platforms and physiological challenges for cancer therapeutics | Q36795110 |
| | Biodegradable, polymeric nanoparticle delivery systems for cancer therapy | Q36988348 |
| | Expression profiling technology: its contribution to our understanding of breast cancer | Q37048774 |
| | The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. | Q37085153 |
| | Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives | Q37130501 |
| | Nanotechnology for breast cancer therapy | Q37229262 |
| | How we got here, where we are going and being a cog in something turning | Q37288962 |
| | Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy | Q37564506 |
| | Identifying subsets of metastatic breast cancer patients likely to benefit from treatment with the epothilone B analog ixabepilone | Q37669032 |
| | In vitro and in vivo imaging with quantum dots | Q37696342 |
| | Therapeutic nanoparticles to combat cancer drug resistance | Q37705482 |
| | Targeting nanoparticles to cancer. | Q37728139 |
| | Use of quantum dots in the development of assays for cancer biomarkers | Q37763620 |
| | Directed self-assembly of nanoparticles. | Q37766843 |
| | Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy | Q37777782 |
| | From nanotechnology to nanomedicine: applications to cancer research | Q37780249 |
| | Cancer nanotechnology: application of nanotechnology in cancer therapy | Q37781428 |
| | Nanomedicine. | Q37821004 |
| | Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations | Q37823446 |
| | Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. | Q37995276 |
| | Targeted anticancer therapy: overexpressed receptors and nanotechnology. | Q38212407 |
| | pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease | Q38976351 |
| | Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation. | Q39005528 |
| | The importance of cellular internalization of antibody-targeted carbon nanotubes in the photothermal ablation of breast cancer cells | Q39604144 |
| | Combinatorial drug conjugation enables nanoparticle dual-drug delivery. | Q39690341 |
| P433 | issue | 2 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 97-108 | |
| P577 | publication date | 2014-09-18 | |
| P1433 | published in | Journal of Drug Targeting | Q6295099 |
| P1476 | title | Nanoparticulate carriers: an emerging tool for breast cancer therapy | |
| P478 | volume | 23 | |